COMPONENT
ROLE
DEFICIENCY OR EXCESS
CLUE
Classical pathway; C1q binds Fc of IgM (one) or IgG (two)
Early classical deficiency (C2 most common) → SLE-like disease, encapsulated infections
Poor immune-complex clearance
Lectin pathway; cleaves C4 and C2 via MASPs
MBL deficiency → infections in infancy
Common, often mild
Factor B · factor D · properdin
Alternative pathway amplification loop on microbial surfaces
Properdin deficiency (X-linked) → Neisseria
—
Central component; C3b opsonizes and forms convertases
C3 deficiency → severe recurrent pyogenic infections (encapsulated), immune-complex GN
Most severe single deficiency
Anaphylatoxins: mast cell histamine release, vasodilation
—
C5a is also the main chemoattractant
Pore in membrane → lysis
Terminal deficiency → recurrent Neisseria (meningococcus, disseminated gonococcus)
Eculizumab (anti-C5) mimics it
Blocks C1r/C1s and kallikrein
Hereditary angioedema (AD): recurrent non-itchy swelling of face, airway, gut; ↓ C4
↑ bradykinin · no urticaria · ACE inhibitors contraindicated · C1-INH concentrate, icatibant, ecallantide
GPI-anchored; disassemble convertase · block MAC on self cells
PNH (acquired PIGA mutation) → intravascular hemolysis, morning hemoglobinuria, thrombosis, pancytopenia
Flow cytometry · eculizumab, ravulizumab
Factor H · factor I · MCP (CD46)
Inactivate C3b on host surfaces
Atypical HUS (non-diarrheal), C3 glomerulopathy, macular degeneration (factor H variants)
Eculizumab for aHUS
CR1 (CD35) · CR2 (CD21) · CR3 (CD11b/CD18)
C3b on RBCs carries immune complexes to spleen · C3d boosts B cells · iC3b phagocytosis
CR3 is defective in LAD
EBV uses CR2
Immune-complex disease uses up C3, C4
↓ C3 + ↓ C4: SLE, cryoglobulinemia, serum sickness · ↓ C3 only: PSGN, MPGN/C3G, aHUS
CH50 screens classical pathway